Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7678619rdf:typepubmed:Citationlld:pubmed
pubmed-article:7678619lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:7678619lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:7678619lifeskim:mentionsumls-concept:C0206527lld:lifeskim
pubmed-article:7678619lifeskim:mentionsumls-concept:C1332709lld:lifeskim
pubmed-article:7678619lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:7678619lifeskim:mentionsumls-concept:C0851827lld:lifeskim
pubmed-article:7678619lifeskim:mentionsumls-concept:C1701901lld:lifeskim
pubmed-article:7678619lifeskim:mentionsumls-concept:C1514485lld:lifeskim
pubmed-article:7678619pubmed:issue3lld:pubmed
pubmed-article:7678619pubmed:dateCreated1993-2-22lld:pubmed
pubmed-article:7678619pubmed:abstractTextStaphylococcal enterotoxins, also known as superantigens (SAg), bind class II MHC molecules on APC and upon direct cell-to-cell contact stimulate proliferation of T cells expressing appropriate V beta gene products. The T cell surface molecule CD28 binds its costimulatory counter-receptor, B7 expressed on APC, and augments IL-2 production and T cell growth. Although the role of B7 costimulation during Ag-specific responses of T cells is established, its involvement during the activation of T cells with SAg has not been examined. Using a soluble Ig C gamma 1 chimera of CTLA-4, a second receptor for B7 and a homologue of CD28, this study examines the role of B7 expressed on APC during the induction of proliferation of CD4+ T cells upon stimulation with SAg (SAg/staphylococcal enterotoxins). CTLA-4lg, which has a higher avidity for B7 than CD28, had no effect on the synthesis of IL-2 as well as proliferative responses of CD4+ T cells induced by SAg presented on allogeneic EBV-transformed B cells, and IFN-gamma-activated endothelial cells. In contrast, T cell proliferation induced by alloAg presentation by the same APC was significantly inhibited by CTLA-4lg. mAb directed at the CD11a/CD18 molecule inhibited both SAg-induced and alloAg-induced proliferation of T cells. AlloAg-primed CD4+ T cells, which expressed both class II MHC and intercellular adhesion molecule-1 but not B7, presented SAg to and induced proliferation of both resting and SAg-primed T cells. These responses were inhibited by mAb directed at CD11a/CD18 but not by CTLA-4 Rg. These results suggest that SAg-induced responses differ from those induced by alloAg in that they are not obligatorily dependent on the costimulation by B7. In contrast, adhesive interaction between CD11a/CD18 on T cells and its counter-receptor on SAg-presenting cells is necessary and probably sufficient to support SAg-induced proliferation of T cells.lld:pubmed
pubmed-article:7678619pubmed:languageenglld:pubmed
pubmed-article:7678619pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7678619pubmed:citationSubsetAIMlld:pubmed
pubmed-article:7678619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7678619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7678619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7678619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7678619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7678619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7678619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7678619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7678619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7678619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7678619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7678619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7678619pubmed:statusMEDLINElld:pubmed
pubmed-article:7678619pubmed:monthFeblld:pubmed
pubmed-article:7678619pubmed:issn0022-1767lld:pubmed
pubmed-article:7678619pubmed:authorpubmed-author:LinsleyP SPSlld:pubmed
pubmed-article:7678619pubmed:authorpubmed-author:DamleN KNKlld:pubmed
pubmed-article:7678619pubmed:authorpubmed-author:KlussmanKKlld:pubmed
pubmed-article:7678619pubmed:authorpubmed-author:LeytzeGGlld:pubmed
pubmed-article:7678619pubmed:issnTypePrintlld:pubmed
pubmed-article:7678619pubmed:day1lld:pubmed
pubmed-article:7678619pubmed:volume150lld:pubmed
pubmed-article:7678619pubmed:ownerNLMlld:pubmed
pubmed-article:7678619pubmed:authorsCompleteYlld:pubmed
pubmed-article:7678619pubmed:pagination726-35lld:pubmed
pubmed-article:7678619pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:7678619pubmed:meshHeadingpubmed-meshheading:7678619-...lld:pubmed
pubmed-article:7678619pubmed:meshHeadingpubmed-meshheading:7678619-...lld:pubmed
pubmed-article:7678619pubmed:meshHeadingpubmed-meshheading:7678619-...lld:pubmed
pubmed-article:7678619pubmed:meshHeadingpubmed-meshheading:7678619-...lld:pubmed
pubmed-article:7678619pubmed:meshHeadingpubmed-meshheading:7678619-...lld:pubmed
pubmed-article:7678619pubmed:meshHeadingpubmed-meshheading:7678619-...lld:pubmed
pubmed-article:7678619pubmed:meshHeadingpubmed-meshheading:7678619-...lld:pubmed
pubmed-article:7678619pubmed:meshHeadingpubmed-meshheading:7678619-...lld:pubmed
pubmed-article:7678619pubmed:meshHeadingpubmed-meshheading:7678619-...lld:pubmed
pubmed-article:7678619pubmed:meshHeadingpubmed-meshheading:7678619-...lld:pubmed
pubmed-article:7678619pubmed:meshHeadingpubmed-meshheading:7678619-...lld:pubmed
pubmed-article:7678619pubmed:meshHeadingpubmed-meshheading:7678619-...lld:pubmed
pubmed-article:7678619pubmed:meshHeadingpubmed-meshheading:7678619-...lld:pubmed
pubmed-article:7678619pubmed:meshHeadingpubmed-meshheading:7678619-...lld:pubmed
pubmed-article:7678619pubmed:meshHeadingpubmed-meshheading:7678619-...lld:pubmed
pubmed-article:7678619pubmed:meshHeadingpubmed-meshheading:7678619-...lld:pubmed
pubmed-article:7678619pubmed:meshHeadingpubmed-meshheading:7678619-...lld:pubmed
pubmed-article:7678619pubmed:meshHeadingpubmed-meshheading:7678619-...lld:pubmed
pubmed-article:7678619pubmed:meshHeadingpubmed-meshheading:7678619-...lld:pubmed
pubmed-article:7678619pubmed:meshHeadingpubmed-meshheading:7678619-...lld:pubmed
pubmed-article:7678619pubmed:year1993lld:pubmed
pubmed-article:7678619pubmed:articleTitleProliferation of human T lymphocytes induced with superantigens is not dependent on costimulation by the CD28 counter-receptor B7.lld:pubmed
pubmed-article:7678619pubmed:affiliationBristol-Myers Squibb Pharmaceutical Research Institute, Seattle, WA 98121.lld:pubmed
pubmed-article:7678619pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7678619lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7678619lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7678619lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7678619lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7678619lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7678619lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7678619lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7678619lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7678619lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7678619lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7678619lld:pubmed